|
|
Achieving SVR Does Not Prevent From Fibrosis Progession In Patients With FCH Results From A Large French Prospective Multicentric ANRS CO23 Cupilt Cohort
Mylene Sebagh
,
Claire Fougerou-Leurent
,
Georges-Philippe Pageaux
,
Vincent Leroy
,
Jerome Dumortier
et al.
Hepatology, 2017, 66, pp.872A-872A
Journal articles
hal-01769633v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Achieving SVR Does Not Prevent From Fibrosis Progression In Patients With FCH: Results From A Large French Prospective Multicentric ANRS CO23 Cupilt Cohort
Mylene Sebagh
,
Claire Fougerou-Leurent
,
Georges-Philippe Pageaux
,
Vincent Leroy
,
Jerome Dumortier
et al.
Hepatology, 2017, 66, pp.872A-872A
Journal articles
hal-01684629v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Long term results of liver transplantation for Wilson's disease: experience in France
Olivier Guillaud
,
Jérôme Dumortier
,
Rodolphe Sobesky
,
Dominique Debray
,
Philippe Wolf
et al.
Journal articles
hal-01068685v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study
Sébastien Dharancy
,
Audrey Coilly
,
Claire Fougerou-Leurent
,
Christophe Duvoux
,
Nassim Kamar
et al.
Journal articles
hal-01640061v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence Prophylaxis makes the difference
Lina Mouna
,
Emilie Rossignol
,
Mariagrazia Tateo
,
Audrey Coilly
,
Jean-Charles Duclos-Vallee
et al.
Journal articles
hal-02120675v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study
Audrey Coilly
,
Claire Fougerou-Leurent
,
Victor De Ledinghen
,
Pauline Houssel-Debry
,
Christophe Duvoux
et al.
Journal articles
hal-01395132v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Determinants of high-grade anal intraepithelial lesions in HIV-positive men having sex with men
Gary M Clifford
,
Laurent Siproudhis
,
Lionel Piroth
,
Isabelle Poizot-Martin
,
Sylvie Radenne
et al.
Journal articles
hal-01862284v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
No evidence of hepatitis B virus reactivation among liver transplant recipients treated with interferon- free regimens for hepatitis C virus recurrence (ANRS CO23 CUPILT Cohort)
Lina Mouna
,
Emilie Rossignol
,
Mariagrazia Tateo
,
Jean-Charles Duclos-Vallee
,
Christophe Duvoux
et al.
Hepatology, 2017, 66, pp.873A-874A
Journal articles
hal-01769634v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values results from the ANRS CO23 CUPILT cohort
Aurélie Barrail-Tran
,
Lauriane Goldwirt
,
Thibaut Gelé
,
Claire Laforest
,
Audrey Lavenu
et al.
Journal articles
hal-02280498v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Efficacy of Sofosbuvir and Daclatasvir in Patients with Fibrosing Cholestatic Hepatitis C After Liver Transplantation
Vincent Leroy
,
Jérôme Dumortier
,
Audrey Coilly
,
Mylène Sebagh
,
Claire Fougerou-Leurent
et al.
Journal articles
hal-01162384v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Microsporidiosis after liver transplantation: A French nationwide retrospective study
Jérôme Dumortier
,
Sylvie Radenne
,
Nassim Kamar
,
Filomena Conti
,
Armand Abergel
et al.
Journal articles
hal-03280899v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria
Helena Degroote
,
Federico Piñero
,
Charlotte Costentin
,
Andrea Notarpaolo
,
Ilka F Boin
et al.
Journal articles
hal-03378783v2
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation
Audrey Coilly
,
Mylene Sebagh
,
C. Fougerou-Leurent
,
Georges-Philippe Pageaux
,
Vincent Leroy
et al.
Journal articles
hal-03799246v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?
Audrey Coilly
,
Jérôme Dumortier
,
Danielle Botta-Fridlund
,
Marianne Latournerie
,
Vincent Leroy
et al.
Journal articles
hal-01326372v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prediction of hepatocellular carcinoma recurrence after liver transplantation: Comparison of four explant-based prognostic models
Charlotte Costentin
,
Giuliana Amaddeo
,
Thomas Decaens
,
Karim Boudjema
,
Philippe Bachellier
et al.
Journal articles
hal-01657280v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Sofosbuvir and NS5A inhibitors without Ribavirin during 12 weeks are efficient to treat hepatitis C recurrence after liver transplantation only in genotype 1. Results from the CO23 ANRS CUPILT study.
Pauline Houssel-Debry
,
Audrey Coilly
,
Claire Fougerou-Leurent
,
Caroline Jezequel
,
Christophe Duvoux
et al.
Hepatology, 2017, 63 (1 SUPP), pp.465A--465A
Journal articles
hal-01412958v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
12 weeks of a Ribavirin-free Sofosbuvir and NS5A inhibitor regimen is enough to treat recurrence of hepatitis C after liver transplantation
Pauline Houssel-Debry
,
Audrey Coilly
,
Claire Fougerou-Leurent
,
Caroline Jezequel
,
Christophe Duvoux
et al.
Journal articles
hal-01807755v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?
Lucy Meunier
,
Mohamed Belkacemi
,
George Philippe Pageaux
,
Sylvie Radenne
,
Anaïs Vallet-Pichard
et al.
Journal articles
hal-03980202v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|